76 results
8-K
EX-99.1
t182k8vn
20 Sep 21
BioCryst Appoints Dr. Amy McKee to Board of Directors
7:06am
8-K
EX-99.1
ja0 vrvap1
22 Jan 21
BioCryst Announces Approval of ORLADEYO™ (berotralstat) in Japan for the Prophylactic Treatment of Hereditary Angioedema
7:12am
424B2
wjnekg
29 May 20
Prospectus for primary offering
6:07am
424B5
cx2j9l25wyjw
27 May 20
Prospectus supplement for primary offering
5:16pm
8-K
EX-99.1
eh8hlml6e0hmr oirlg5
30 Mar 20
Other Events
7:20am
8-K
EX-99.1
yvs6q
25 Feb 20
BioCryst Appoints Alan G. Levin to Board of Directors
7:05am
8-K
EX-99.1
7brrfcjxbu3e97 oj
5 Nov 19
BioCryst Announces Partnership With Torii Pharmaceutical to Commercialize BCX7353 in Japan for the Prevention of HAE Attacks
7:02am